Literature DB >> 3060825

Demonstration of opsonic and protective activity of human cord sera against type III group B streptococcus that are independent of type-specific antibody.

K S Kim1, C A Wass, J K Hong, N F Concepcion, B F Anthony.   

Abstract

In an effort to further understand the host defense against group B streptococcus (GBS), we examined 71 human cord sera for their content of type III GBS IgG antibody by enzyme-linked immunosorbent assay and correlated the results with opsonic and protective activity against type III GBS. Most cord sera (67%) containing greater than 0.1 microgram/ml of type III GBS IgG antibody promoted phagocytosis and killing in vitro and protection against type III GBS in neonatal rats. However, 26% of cord sera containing less than 0.1 microgram/ml of type III IgG antibody exhibited similar activity in vitro and in vivo against type III GBS. This opsonic and protective activity was retained in IgG fraction of whole serum, and was not directly associated with complement activity or with fibronectin. Further studies are needed to understand the mechanisms responsible for the opsonic and protective activity of some cord sera against type III GBS that may be independent of antibody to the type-specific polysaccharide antigen.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3060825     DOI: 10.1203/00006450-198811000-00018

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  5 in total

1.  Nonopsonic binding of type III Group B Streptococci to human neutrophils induces interleukin-8 release mediated by the p38 mitogen-activated protein kinase pathway.

Authors:  E A Albanyan; J G Vallejo; C W Smith; M S Edwards
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

2.  A human IgG 3 is opsonic in vitro against type III group B streptococci.

Authors:  J S Kim; K S Kim; C A Wass; J A Short; D C Heiner
Journal:  J Clin Immunol       Date:  1990-05       Impact factor: 8.317

3.  Association between low concentrations of antibodies to protein alpha and Rib and invasive neonatal group B streptococcal infection.

Authors:  C Larsson; M Lindroth; P Nordin; M Stålhammar-Carlemalm; G Lindahl; I Krantz
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2006-11       Impact factor: 5.747

4.  Antibodies present in normal human serum inhibit invasion of human brain microvascular endothelial cells by Listeria monocytogenes.

Authors:  Tobias Hertzig; Martin Weber; Lars Greiffenberg; Britta Schulte Holthausen; Werner Goebel; Kwang Sik Kim; Michael Kuhn
Journal:  Infect Immun       Date:  2003-01       Impact factor: 3.441

5.  Protein rib: a novel group B streptococcal cell surface protein that confers protective immunity and is expressed by most strains causing invasive infections.

Authors:  M Stålhammar-Carlemalm; L Stenberg; G Lindahl
Journal:  J Exp Med       Date:  1993-06-01       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.